Research
What Is TB-500? A Complete Research Overview
TB-500 (Thymosin Beta-4 fragment) is a synthetic peptide composed of 43 amino acids, derived from a specific region of Thymosin Beta-4 — a naturally occurring protein found in virtually all human and animal cells. It has become one of the most studied peptides in preclinical tissue repair and cell biology research, with a body of literature examining its roles in actin binding, cell migration, angiogenesis, and inflammatory pathway modulation.
This article provides a comprehensive overview of TB-500 for researchers, covering its molecular structure, proposed mechanisms of action, preclinical research landscape, relationship to Thymosin Beta-4, and considerations for laboratory use.
What Does TB-500 Stand For?
TB-500 is a synthetic analog of the active region of Thymosin Beta-4 (Tβ4), a 43-amino acid protein encoded by the TMSB4X gene. The “TB” designation refers to Thymosin Beta, a family of actin-sequestering proteins first identified in thymic tissue. “500” refers to its identification number within peptide research catalogues.
The active region of Thymosin Beta-4 responsible for most of its studied biological effects is the actin-binding domain, specifically the tetrapeptide sequence Ac-SDKP (N-acetyl-seryl-aspartyl-lysyl-proline). TB-500 is a synthetic peptide encompassing this region.
- Sequence: Ac-LKKTETQ (17-mer active fragment, varies by synthesis)
- Molecular Weight: 4,963 Da
- CAS Number: 77591-33-4
- Type: Synthetic Thymosin Beta-4 fragment
- Form: Lyophilized powder
TB-500 Mechanism of Action: What Preclinical Research Suggests
Research into TB-500 has proposed several distinct mechanisms through which it may exert biological effects in preclinical models:
1. Actin Binding and Cytoskeletal Dynamics
TB-500’s primary studied mechanism is its interaction with G-actin (globular actin), the monomeric form of actin that polymerizes to form F-actin filaments — the structural backbone of the cell cytoskeleton. By sequestering G-actin, TB-500 influences cytoskeletal dynamics, which in turn affects cell shape, motility, and division. This mechanism is foundational to understanding TB-500’s downstream effects in cell migration and tissue repair research.
2. Cell Migration Facilitation
One of the most consistently reported effects of TB-500 in preclinical literature is its promotion of cell migration. Research has demonstrated TB-500’s ability to upregulate cell migration in multiple cell types including endothelial cells, keratinocytes, and stem cells. This effect is believed to be downstream of its actin-binding mechanism and is a key reason TB-500 is studied extensively in wound healing and tissue repair models.
3. Angiogenesis
TB-500 has been shown in preclinical models to promote angiogenesis — the formation of new blood vessels — through upregulation of vascular endothelial growth factor (VEGF) receptor expression and promotion of endothelial cell migration and tube formation. This angiogenic activity is relevant to research examining vascular repair, wound healing, and cardiac tissue biology.
4. Anti-Inflammatory Signaling
Preclinical research has examined TB-500’s interactions with inflammatory signaling pathways. Studies have reported reductions in inflammatory cytokines and modulation of NF-κB pathway activity in TB-500 treated models, suggesting a potential role in inflammatory pathway research beyond its primary cytoskeletal mechanism.
5. Stem Cell Recruitment
Emerging preclinical literature has examined TB-500’s potential role in stem cell recruitment and mobilization, with studies suggesting it may promote the migration of progenitor cells to sites of tissue injury in animal models.
TB-500 vs Thymosin Beta-4: What Is the Difference?
TB-500 and Thymosin Beta-4 are related but distinct compounds that are frequently confused in research literature.
Thymosin Beta-4 (Tβ4) is a naturally occurring 43-amino acid protein found in most human and animal cells. It plays a fundamental role in actin dynamics and cell cytoskeletal organization. It has been studied extensively in cardiac repair, wound healing, and corneal research.
TB-500 is a synthetic peptide analog derived from the active region of Thymosin Beta-4. It is not identical to Thymosin Beta-4 but shares its primary actin-binding domain and many of its studied biological properties.
| Thymosin Beta-4 | TB-500 | |
|---|---|---|
| Type | Naturally occurring protein | Synthetic peptide analog |
| Length | 43 amino acids (full sequence) | 17-mer active fragment |
| Origin | Endogenous | Synthetic |
| Research Use | Broad cell biology research | Tissue repair, cell migration |
For most preclinical research applications, TB-500 is used as a research tool to study the biological effects associated with Thymosin Beta-4’s active region.
TB-500 Preclinical Research Landscape
TB-500 has accumulated a substantial body of preclinical literature across multiple research domains:
Wound Healing and Tissue Repair Research
TB-500 is among the most studied peptides in preclinical wound healing research. Animal models have examined its effects in skin wound closure, tendon repair, ligament healing, and muscle injury models. Studies consistently report accelerated wound closure and improved tissue remodeling parameters in TB-500 treated groups compared to controls.
Cardiac Research
A notable body of preclinical literature has examined TB-500 in cardiac biology, including studies of cardiac repair following experimentally induced myocardial injury in animal models. Research has examined its effects on cardiomyocyte survival, cardiac progenitor cell recruitment, and vascular repair in the cardiac tissue context.
Corneal and Ocular Research
TB-500 has been studied extensively in corneal biology, with preclinical and some clinical research examining its effects on corneal wound healing, epithelial cell migration, and dry eye models. This is one of the more clinically advanced research areas for Thymosin Beta-4 and its analogs.
Neurological Research
Emerging preclinical literature has examined TB-500 in neurological contexts, including research into neuroprotection and neural repair mechanisms following experimental injury in animal models.
Musculoskeletal Research
TB-500 has been studied in preclinical orthopedic models examining tendon and ligament biology, with research investigating its effects on fibroblast activity, collagen synthesis, and structural repair outcomes in injury models.
TB-500 vs BPC-157: Key Differences for Researchers
TB-500 and BPC-157 are frequently studied together in preclinical tissue repair research. While both peptides are associated with repair pathway signaling, they have distinct molecular structures and primary mechanisms.
| TB-500 | BPC-157 | |
|---|---|---|
| Type | Thymosin Beta-4 fragment | Pentadecapeptide |
| Size | 43 amino acids | 15 amino acids |
| Primary Mechanism | Actin binding / cell migration | NO system / VEGF signaling |
| Key Research Area | Cell motility, wound healing | GI, tissue repair, neuroprotection |
| Origin | Derived from endogenous protein | Derived from gastric juice protein |
Researchers studying multi-pathway tissue repair models frequently use both compounds in parallel experimental designs, hypothesizing that their complementary mechanisms may produce additive effects. For a detailed comparison, see our BPC-157 research overview.
Regulatory Status of TB-500
FDA Status: TB-500 is not approved by the U.S. Food and Drug Administration as a drug, supplement, or food additive. It is classified as a research chemical for in vitro and laboratory use only.
Legal Status: TB-500 is not a DEA-scheduled substance in the United States. Its sale and possession as a research chemical are legal, provided it is clearly labeled and sold for research use only with no implied or explicit claims of human consumption.
TB-500 Quality Standards for Research Use
For researchers sourcing TB-500 for laboratory use, the same quality parameters that apply to any research peptide apply here:
Purity: Research-grade TB-500 should meet a minimum purity threshold of 98%, with premium suppliers achieving 99%+ purity verified via HPLC analysis.
Identity Verification: Mass spectrometry confirms the correct molecular weight and fragmentation pattern matching TB-500’s known profile.
Certificate of Analysis: Every batch should be accompanied by a batch-specific COA documenting HPLC purity, mass spec confirmation, and lot information. All Peak Lab TB-500 is independently tested to 99%+ purity with a batch COA included with every order. Learn more about our peptide purity testing standards.
Storage: Store lyophilized TB-500 at -20°C long term. Once reconstituted with bacteriostatic water, store at 4°C and use within 28 days.
Frequently Asked Questions About TB-500
What is TB-500 used for in research? TB-500 is used as a tool compound in preclinical research investigating cell migration mechanisms, wound healing signaling, angiogenesis, actin cytoskeletal dynamics, and tissue repair pathways. All documented research has been conducted in in vitro systems or animal models.
Is TB-500 the same as Thymosin Beta-4? No. TB-500 is a synthetic peptide analog derived from the active region of Thymosin Beta-4. It shares Thymosin Beta-4’s primary actin-binding domain and many studied biological properties but is not identical to the full 43-amino acid endogenous protein.
What purity should TB-500 be for research? Research-grade TB-500 should be sourced at a minimum purity of 98%, verified by HPLC analysis. Leading research chemical suppliers provide 99%+ purity with batch-specific COAs.
How does TB-500 differ from BPC-157? TB-500 is a Thymosin Beta-4 fragment primarily associated with actin-binding and cell migration mechanisms. BPC-157 is a pentadecapeptide primarily associated with nitric oxide system and VEGF pathway modulation. Both are studied in tissue repair research but through distinct molecular pathways.
Can TB-500 be used in humans? TB-500 is not approved for human use by the FDA or any major international regulatory body. It is classified as a research chemical for in vitro and laboratory research purposes only.
All content on Peak Lab Peptides is provided for educational and research purposes only. TB-500 is intended for in vitro laboratory research use only and is not approved for human or veterinary use, consumption, or medical applications. Researchers should comply with all applicable local, national, and international regulations.